Profil
Steven Cha worked as Chief Medical Officer at Imugene Ltd. in 2022.
Dr. Cha worked as Chief Medical Officer at NKGen Operating Biotech, Inc. Dr. Cha worked as Senior Vice President-Clinical Research at Processa Pharmaceuticals, Inc. Dr. Cha completed undergraduate studies at the University of California San Diego and earned a doctorate from Tufts University School of Medicine.
Ehemalige bekannte Positionen von Steven Cha
| Unternehmen | Position | Ende |
|---|---|---|
| IMUGENE LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2022 |
| PROCESSA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Steven Cha
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Health Technology |
















